These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28399911)

  • 1. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
    Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer.
    Zhou XJ; Wu J; Shi L; Li XX; Zhu L; Sun X; Qian JY; Wang Y; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2017 Oct; 36(1):149. PubMed ID: 29052531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer.
    Wu J; Zhou XJ; Sun X; Xia TS; Li XX; Shi L; Zhu L; Zhou WB; Wei JF; Ding Q
    Br J Cancer; 2017 Aug; 117(5):675-684. PubMed ID: 28683467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
    Zhang M; Xu E; Zhang J; Chen X
    Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein RBM38 inhibits colorectal cancer progression by partly and competitively binding to PTEN 3'UTR with miR-92a-3p.
    Guan B; Li G; Wan B; Guo X; Huang D; Ma J; Gong P; Guo J; Bu Y
    Environ Toxicol; 2021 Dec; 36(12):2436-2447. PubMed ID: 34453780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.
    Shen H; Zhao L; Feng X; Xu C; Li C; Niu Y
    Oncotarget; 2016 Sep; 7(37):60407-60418. PubMed ID: 27494865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
    Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
    Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N; Hill AD; Young LS
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
    Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
    Xiong J; Du Q; Liang Z
    Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins.
    Balmer LA; Beveridge DJ; Jazayeri JA; Thomson AM; Walker CE; Leedman PJ
    Mol Cell Biol; 2001 Mar; 21(6):2070-84. PubMed ID: 11238942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer.
    Sun X; Hu Y; Wu J; Shi L; Zhu L; Xi PW; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2018 Dec; 37(1):298. PubMed ID: 30514345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
    Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
    Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRC Increases
    Abdullah C; Korkaya H; Iizuka S; Courtneidge SA
    Mol Cell Biol; 2018 Mar; 38(6):. PubMed ID: 29263157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
    Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
    Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
    Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of RNA-binding protein RBM38 decreased in renal cell carcinoma and represses renal cancer cell proliferation, migration, and invasion.
    Huang W; Wei XL; Ni W; Cao M; Meng L; Yang H
    Tumour Biol; 2017 May; 39(5):1010428317701635. PubMed ID: 28459215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
    Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
    Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.